Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-hodgkin's lymphoma

Cancer ◽

10.1002/(sici)1097-0142(19980301)82:5<957::aid-cncr22>3.0.co;2-z ◽

1998 ◽

Vol 82 (5) ◽

pp. 957-964 ◽

Author(s):

Lynn R. Kong ◽

Cheng-Fang Huang ◽

David Hakimian ◽

Daina Variakojis ◽

Leonard Klein ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Late Complications ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up ◽

Previously Treated

Download Full-text

Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma

Cancer ◽

10.1002/(sici)1097-0142(19990101)85:1<242::aid-cncr34>3.0.co;2-r ◽

1999 ◽

Vol 85 (1) ◽

pp. 242-243

Author(s):

Meral Beksa� ◽

Mutlu Arat ◽

Ramazan Idilman

Keyword(s):

Hodgkin’S Lymphoma ◽

Late Complications ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up ◽

Previously Treated

Download Full-text

A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant

Leukemia ◽

10.1038/sj.leu.2403427 ◽

2004 ◽

Vol 18 (10) ◽

pp. 1717-1721 ◽

Author(s):

J Ph Laporte ◽

M Yeshurun ◽

L Fouillard ◽

M Labopin ◽

C Cailliot ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

High Dose ◽

Dose Intensification ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up

Download Full-text

Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure

Bone Marrow Transplantation ◽

10.1038/bmt.2009.152 ◽

2009 ◽

Vol 45 (2) ◽

pp. 303-309 ◽

Author(s):

J E Benjamin ◽

G L Chen ◽

T M Cao ◽

P D Cao ◽

R M Wong ◽

...

Keyword(s):

B Cell ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up ◽

Induction Failure ◽

Download Full-text

TREATMENT WITH COMBINATION OF LENALIDOMIDE AND RITUXIMAB ACHIEVES DURABLE RESPONSES IN A LONG TERM FOLLOW UP OF PATIENTS WITH INDOLENT NON-HODGKIN'S LYMPHOMA

Hematological Oncology ◽

10.1002/hon.2438_79 ◽

2017 ◽

Vol 35 ◽

pp. 215-216 ◽

Author(s):

M. Chaudhry ◽

L. Nastoupil ◽

F. Samaniego ◽

S.S. Neelapu ◽

F.B. Hagemeister ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up

Download Full-text

Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma

British Journal of Cancer ◽

10.1038/sj.bjc.6601675 ◽

2004 ◽

Vol 90 (6) ◽

pp. 1151-1155 ◽

Author(s):

J Spicer ◽

P Smith ◽

K Maclennan ◽

P Hoskin ◽

B Hancock ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Early Stage ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up ◽

Radiotherapy Alone

Download Full-text

Long term follow-up of CEOP in the treatment of HIV related non-Hodgkin's lymphoma (NHL)

Australian and New Zealand Journal of Medicine ◽

10.1111/j.1445-5994.1998.tb04455.x ◽

1998 ◽

Vol 28 (1) ◽

pp. 28-32 ◽

Author(s):

A. J. Davis ◽

D. Goldstein ◽

S. Milliken

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up

Download Full-text

Radio-Immunotherapy (RIT): Long-term Follow-up Results with I-131 Labeled Antibody in 52 Patients with Non-Hodgkin's Lymphoma (NHL) Refractory to Chemotherapy and Rituxan

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2008.06.1403 ◽

2008 ◽

Vol 72 (1) ◽

pp. S474

Author(s):

J.B. Colenda ◽

R. Mark ◽

P. Anderson ◽

T. Neumann ◽

M. Nair ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up

Download Full-text

Long-term follow-up of paclitaxel and topotecan plus rituximab (TTR) for patients with relapsed and refractory B-cell non-Hodgkin’s lymphoma

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8599 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8599-8599

Author(s):

G. K. Suh ◽

P. McLaughlin ◽

J. E. Romaguera ◽

F. B. Hagemeister ◽

B. Pro ◽

...

Keyword(s):

B Cell ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up

Download Full-text

The cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COPBLAM-I) regimen for intermediate-grade non-Hodgkin's lymphoma. Long term follow-up in 51 patients

Cancer ◽

10.1002/1097-0142(19941201)74:11<3029::aid-cncr2820741121>3.0.co;2-d ◽

1994 ◽

Vol 74 (11) ◽

pp. 3029-3033 ◽

Author(s):

Ofer Shpilberg ◽

Jacob Shif ◽

Angela Chetrit ◽

Bracha Ramot ◽

Isaac Ben-Bassat

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Intermediate Grade ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up

Download Full-text

Bexxar, iodine I 131 tositumomab, Effective in Long Term Follow-up of Non-Hodgkin's Lymphoma

Cancer Biology & Therapy ◽

10.4161/cbt.6.7.4678 ◽

2007 ◽

Vol 6 (7) ◽

pp. 1001-1002

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Long Term Follow Up

Download Full-text